* Dr. Carlsson asserts that prostate cancer screening is moving toward integrated, risk-adapted models, combining PSA, biomarkers, imaging, and AI to optimize outcomes for men globally.
Dr. Sigrid Carlsson, MD, PhD, MPH, Head, Division of Clinical Epidemiology of Early Cancer Detection, DKFZ German Cancer Research Center, Heidelberg, Germany, reviews future directions in prostate cancer screening. She emphasizes that despite available screening, men continue to die of prostate cancer, and opportunistic, non-standardized...
ExcelMale Newsletter Signup
Stay Informed with Our Newsletter
Get the latest men's health insights, expert advice, and community updates delivered to your inbox.